Furthermore, the efficacy and safety of two anti-IL8 antibodies, ABX-CXCL8 and HuMax-IL8/BMS-986253, has been studied in COPD and metastatic or unresectable solid tumors (Bilusic et al. 2019; Mahler et al. 2004). The gene discussed is CXCL8; the disease is chronic obstructive pulmonary disease.